Astragaloside-IV protects H9C2(2-1) cardiomyocytes from high glucose-induced injury via miR-34a-mediated autophagy pathway

References

• Li L, Hou X, Xu R, et al. Research review on the pharmacological effects of astragaloside IV. Fundam Clin Pharmacol. 2017;31(1):17–36.
   PubMed Web of Science ®Google Scholar
• Du J, Liu J, Zhen J, et al. Astragaloside IV protects cardiomyocytes from hypoxia-induced injury by down-regulation of lncRNA GAS5. Biomed Pharmacother. 2019;116:109028.
   PubMed Web of Science ®Google Scholar
• Wang SG, Xu Y, Xie H, et al. AS-IV prevents lipopolysaccharide-induced injury in H9C2 cardiomyocytes. Chin J Nat Med. 2015;13(2):127–132.
   PubMed Web of Science ®Google Scholar
• Zheng Q, Zhu JZ, Bao XY, et al. A preclinical systematic review and meta-analysis of AS-IV for myocardial ischemia/reperfusion injury. Front Physiol. 2018;9:795.
   PubMed Web of Science ®Google Scholar
• Russell J, Du Toit EF, Peart JN, et al. Headrick. Myocyte membrane and microdomain modifications in diabetes: determinants of ischemic tolerance and cardioprotection. Cardiovasc Diabetol. 2017;16(1):155.
   PubMed Web of Science ®Google Scholar
• Hölscher ME, Bode C, Bugger H. Diabetic cardiomyopathy: does the type of diabetes matter? IJMS. 2016;17(12):2136.
   Web of Science ®Google Scholar
• Yang KC, Yamada KA, Patel AY, et al. Deep RNA sequencing reveals dynamic regulation of myocardial noncoding RNAs in failing human heart and remodeling with mechanical circulatory support. Circulation. 2014;129(9):1009–1021.
   PubMed Web of Science ®Google Scholar
• Sun T, Li MY, Li PF, et al. MicroRNAs in cardiac autophagy: small molecules and big role. Cells. 2018;7(8):104
   PubMed Web of Science ®Google Scholar
• Bei Y, Tao L, Cretoiu D, et al. MicroRNAs mediate beneficial effects of exercise in heart. Adv Exp Med Biol. 2017;1000:261–280.
   PubMed Web of Science ®Google Scholar
• Tao H, Song ZY, Ding XS, et al. LncRNAs and miRs as epigenetic signatures in diabetic cardiac fibrosis: new advances and perspectives. Endocrine. 2018;62(2):281–291.
   PubMed Web of Science ®Google Scholar
• de la Ballina LR, Munson MJ, Simonsen A. Lipids and lipid-binding proteins in selective autophagy. J Mol Biol. 2019;pii:S0022-2836(19):30352–30353.
   Web of Science ®Google Scholar
• Mellor KM, Bell JR, Young MJ, et al. Myocardial autophagy activation and suppressed survival signaling is associated with insulin resistance in fructose-fed mice. J Mol Cell Cardiol. 2011;50(6):1035–1043.
   PubMed Web of Science ®Google Scholar
• Guan Y, Zhou L, Zhang Y, et al. Effects of PP2A/Nrf2 on experimental diabetes mellitus-related cardiomyopathy by regulation of autophagy and apoptosis through ROS dependent pathway. Cell Signal. 2019;62:109339.
   PubMed Web of Science ®Google Scholar
• Sciarretta S, Hariharan N, Monden Y, et al. Is autophagy in response to ischemia and reperfusion protective or detrimental for the heart? Pediatr Cardiol. 2011;32(3):275–281.
   PubMed Web of Science ®Google Scholar
• Barlow AD, Thomas DC. Autophagy in diabetes: β-cell dysfunction, insulin resistance, and complications. DNA Cell Biol. 2015;34(4):252–260.
   PubMed Web of Science ®Google Scholar
• Rusanova I, Fernández-Martínez J, Fernández-Ortiz M, et al. Involvement of plasma miRNAs, muscle miRNAs and mitochondrial miRNAs in the pathophysiology of frailty. Exp Gerontol. 2019;124:110637.
   PubMed Web of Science ®Google Scholar
• Brindley E, Hill TDM, Henshall DC. MicroRNAs as biomarkers and treatment targets in status epilepticus. Epilepsy Behav. 2019;3:pii: S1525-5050(19)30353-1.
   Google Scholar
• Subramaniam S, Jeet V, Clements JA, et al. Emergence of microRNAs as key players in cancer cell metabolism. Clin Chem. 2019;17:pii: clinchem.2018.299651.
   Google Scholar
• Lagos-Quintana M, Rauhut R, Yalcin A, et al. Identification of tissue-specific microRNAs from mouse. Curr Biol. 2002;12(9):735–739.
   PubMed Web of Science ®Google Scholar
• Lv J, Zhang Z, Pan L, et al. MicroRNA-34/449 family and viral infections. Virus Res. 2019;260:1–6.
   PubMed Web of Science ®Google Scholar
• Angelini F, Pagano F, Bordin A, et al. Getting old through the blood: circulating molecules in aging and senescence of cardiovascular regenerative cells. Front Cardiovasc Med. 2017;4:62.
   PubMed Web of Science ®Google Scholar
• Yang Y, Cheng HW, Qiu Y, et al. MicroRNA-34a plays a key role in cardiac repair and regeneration following myocardial infarction. Circ Res. 2015;117(5):450–459.
   PubMed Web of Science ®Google Scholar
• Kong L, Zhu J, Han W, et al. Significance of serum microRNAs in pre-diabetes and newly diagnosed type 2 diabetes: a clinical study. Acta Diabetol. 2011;48(1):61–69.
   PubMed Web of Science ®Google Scholar
• Boon RA, Iekushi K, Lechner S, et al. MicroRNA-34a regulates cardiac ageing and function. Nature. 2013;495(7439):107–110.
   PubMed Web of Science ®Google Scholar
• Piegari E, Russo R, Cappetta D, et al. MicroRNA-34a regulates doxorubicin-induced cardiotoxicity in rat. Oncotarget. 2016;7(38):62312–62326.
   PubMedGoogle Scholar
• Ogata M, Hino S, Saito A, et al. Autophagy is activated for cell survival after endoplasmic reticulum stress. Mol Biol Cell. 2006;26(24):9220–9231.
   Web of Science ®Google Scholar
• Berardi DE, Campodónico PB, Díaz Bessone MI, et al. Autophagy: friend or foe in breast cancer development, progression, and treatment. Int J Breast Cancer. 2011;2011:1.
   Google Scholar
• Zou M, Lu N, Hu C, et al. Beclin 1-mediated autophagy in hepatocellular carcinoma cells: implication in anticancer efficiency of oroxylin A via inhibition of mTOR signaling. Cell Signal. 2012;24(8):1722–1732.
   PubMed Web of Science ®Google Scholar
• Harper JW, Schulman BA. Structural complexity in ubiquitin recognition. Cell. 2006;124(6):1133–1136.
   PubMed Web of Science ®Google Scholar
• Danieli A, Martens S. p62-mediated phase separation at the intersection of the ubiquitin-proteasome system and autophagy. J Cell Sci. 2018;131(19):pii:jcs214304.
   PubMed Web of Science ®Google Scholar
• Klionsky DJ, Abdelmohsen K, Abe A, et al. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy. 2016;12(1):1–222.
   PubMed Web of Science ®Google Scholar
• Li L, Yuan L, Luo J, et al. MiR-34a inhibits proliferation and migration of breast cancer through down-regulation of Bcl-2 and SIRT1. Clin Exp Med. 2013;13(2):109–117.
   PubMed Web of Science ®Google Scholar
• Yang J, Chen D, He Y, et al. MiR-34 modulates Caenorhabditis elegans lifespan via repressing the autophagy gene atg9. Age (Dordr). 2013;35(1):11–22.
   PubMed Web of Science ®Google Scholar
• Koukourakis MI, Giatromanolaki A, Sivridis E, et al. Beclin 1 over- and underexpression in colorectal cancer: distinct patterns relate to prognosis and tumour hypoxia. Br J Cancer. 2010;103(8):1209–1214.
   PubMed Web of Science ®Google Scholar
• Maejima Y, Kyoi S, Zhai P, et al. Mst1 inhibits autophagy by promoting the interaction between Beclin1 and Bcl-2. Nat Med. 2013;19(11):1478–1488.
   PubMed Web of Science ®Google Scholar
• Russell RC, Tian Y, Yuan H, et al. ULK1 induces autophagy by phosphorylating Beclin-1 and activating VPS34 lipid kinase. Nat Cell Biol. 2013;15(7):741–750.
   PubMed Web of Science ®Google Scholar
• Kubli DA, Gustafsso AB. Unbreak my heart: targeting mitochondrial autophagy in diabetic cardiomyopathy. Antioxid Redox Signal. 2015;22(17):1527–1544.
   PubMed Web of Science ®Google Scholar
• Karbasforooshan H, Karimi G. The role of SIRT1 in diabetic cardiomyopathy. Biomed Pharmacother. 2017;90:386–392.
   PubMed Web of Science ®Google Scholar
• Kitada M, Ogura Y, Monno I, et al. Sirtuins and type 2 diabetes: role in inflammation, oxidative stress, and mitochondrial function. Front Endocrinol. 2019;10:187.
   PubMed Web of Science ®Google Scholar
• Tabuchi T, Satoh M, Itoh T, et al. MicroRNA-34a regulates the longevity-associated protein SIRT1 in coronary artery disease: effect of statins on SIRT1 and microRNA-34a expression. Clin Sci (Lond). 2012;123(3):161–171.
   PubMed Web of Science ®Google Scholar
• Nnah IC, Wang B, Saqcena C, et al. TFEB-driven endocytosis coordinates MTORC1 signaling and autophagy. Autophagy. 2019;15(1):151–164.
   PubMed Web of Science ®Google Scholar
• Dludla PV, Joubert E, Muller CJF, et al. Hyperglycemia-induced oxidative stress and heart disease-cardioprotective effects of rooibos flavonoids and phenylpyruvic acid-2-O-β-D-glucoside. Nutr Metab (Lond). 2017;14:45.
   PubMed Web of Science ®Google Scholar
• He Y, Xi J, Zheng H, et al. Astragaloside IV inhibits oxidative stress-induced mitochondrial permeability transition pore opening by inactivating GSK-3β via nitric oxide in H9c2 cardiac cells. Oxid Med Cell Longev. 2012;2012:1.
   Web of Science ®Google Scholar
• Song G, Han P, Sun H, et al. AS-IV ameliorates early diabetic nephropathy by inhibition of MEK1/2-ERK1/2-RSK2 signaling in streptozotocin-induced diabetic mice. J Int Med Res. 2018;46(7):2883–2897.
   PubMed Web of Science ®Google Scholar
• He KQ, Li WZ, Chai XQ, et al. AS-IV prevents kidney injury caused by iatrogenic hyperinsulinemia in a streptozotocin-induced diabetic rat model. Int J Mol Med. 2018;41(2):1078–1088.
   PubMed Web of Science ®Google Scholar
• Jia Y, Zuo D, Li Z, et al. AS-IV inhibits doxorubicin-induced cardiomyocyte apoptosis mediated by mitochondrial apoptotic pathway via activating the PI3K/Akt pathway. Chem Pharm Bull. 2014;62(1):45–53.
   PubMed Web of Science ®Google Scholar